C237-0195 Screening compound: N'-(3,4-dimethoxyphenyl)-N-[2-(3,5-dimethylpiperidin-1-yl)-4-methylquinolin-6-yl]butanediamide

C237-0195 Screening compound: N'-(3,4-dimethoxyphenyl)-N-[2-(3,5-dimethylpiperidin-1-yl)-4-methylquinolin-6-yl]butanediamide
C237-0195 Screening compound: N'-(3,4-dimethoxyphenyl)-N-[2-(3,5-dimethylpiperidin-1-yl)-4-methylquinolin-6-yl]butanediamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C237-0195
N'-(3,4-dimethoxyphenyl)-N-[2-(3,5-dimethylpiperidin-1-yl)-4-methylquinolin-6-yl]butanediamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C237-0195

Molecular Formula

C29H36N4O4 (C29 H36 N4 O4)

Compound Name

N'-(3,4-dimethoxyphenyl)-N-[2-(3,5-dimethylpiperidin-1-yl)-4-methylquinolin-6-yl]butanediamide

IUPAC name

N'-(34-dimethoxyphenyl)-N-[2-(35-dimethylpiperidin-1-yl)-4-methylquinolin-6-yl]butanediamide

SMILES

CC(CC(C)C1)CN1c1cc(C)c(cc(cc2)NC(CCC(Nc(cc3)cc(OC)c3OC)=O)=O)c2n1

InChI

InChI=1S/C29H36N4O4/c1-18-12-19(2)17-33(16-18)27-13-20(3)23-14-21(6-8-24(23)32-27)30-28(34)10-11-29(35)31-22-7-9-25(36-4)26(15-22)37-5/h6-9,13-15,18-19H,10-12,16-17H2,1-5H3,(H,30,34)(H,31,35)

InChI Key

AULDGWHRGBLMEZ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14733762

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

504.63

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

5.022

Distribution Coefficient, logD

5.022

Water Solubility, LogSw

-4.79

Polar Surface Area

72.640

Acid Dissociation Constant (pKa)

11.10

Base Dissociation Constant (pKb)

9.48

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

41.40

C237-0195 in Drug Discovery

Included in Screening Libraries

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with C237-0195 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C237-0195?
Check Price and Availability of C237-0195, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C237-0195 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C237-0195
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C237-0195
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C237-0195 available by request